Exane Derivatives’s Sabesp SBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5
Closed -$6 731
2018
Q3
$6 Hold
5
﹤0.01% 686
2018
Q2
$6 Hold
5
﹤0.01% 680
2018
Q1
$10 Sell
5
-16,336
-100% -$35.1K ﹤0.01% 619
2017
Q4
$33.1K Sell
16,341
-6,822
-29% -$13.1K 0.01% 367
2017
Q3
$47K Buy
23,163
+9,323
+67% +$18.8K 0.01% 311
2017
Q2
$25.5K Buy
13,840
+4,667
+51% +$8.62K 0.01% 353
2017
Q1
$18.5K Sell
9,173
-41,825
-82% -$82.5K ﹤0.01% 329
2016
Q4
$85.8K Buy
50,998
+34,544
+210% +$60.8K 0.02% 257
2016
Q3
$29.5K Hold
16,454
﹤0.01% 335
2016
Q2
$28.6K Sell
16,454
-10,314
-39% -$15K ﹤0.01% 311
2016
Q1
$34.3K Buy
26,768
+1,315
+5% +$1.39K ﹤0.01% 347
2015
Q4
$22.7K Sell
25,453
-14,438
-36% -$13K ﹤0.01% 287
2015
Q3
$30K Sell
39,891
-51,354
-56% -$46.1K ﹤0.01% 302
2015
Q2
$91.7K Buy
91,245
+33,544
+58% +$37.8K 0.01% 252
2015
Q1
$60.6K Sell
57,701
-80,499
-58% -$86.2K 0.01% 299
2014
Q4
$169K Buy
+138,200
New +$197K 0.02% 235

Other funds holding SBS

Exane Derivatives's SBS Position: Q4 2018 in Review

Exane Derivatives sold out of Sabesp (SBS) in Q4 2018, closing a stake of 5 shares — an estimated $6 sold.

Exane Derivatives first reported a position in SBS in Q4 2014 and held it in 16 quarters. The position peaked at $169K in Q4 2014. 173 funds tracked by Wall St. Rank hold SBS as of Q4 2018.

  • Exane Derivatives reported no remaining Sabesp position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 5 Sabesp shares in Q4 2018, an estimated $6.
  • Exane Derivatives first reported a position in Sabesp in Q4 2014 and held it in 16 quarters.
  • Exane Derivatives's Sabesp position peaked at $169K in Q4 2014.
  • 173 funds tracked by Wall St. Rank held Sabesp as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.